324 related articles for article (PubMed ID: 35033015)
21. Management of Ulcerative Colitis Flare-Ups in the Era of COVID-19.
Mounsif S; Setouani H; Nadi A; Ghalim F; Delsa H
Cureus; 2022 Dec; 14(12):e32153. PubMed ID: 36601162
[TBL] [Abstract][Full Text] [Related]
22. Effects of oral tacrolimus as a rapid induction therapy in ulcerative colitis.
Kawakami K; Inoue T; Murano M; Narabayashi K; Nouda S; Ishida K; Abe Y; Nogami K; Hida N; Yamagami H; Watanabe K; Umegaki E; Nakamura S; Arakawa T; Higuchi K
World J Gastroenterol; 2015 Feb; 21(6):1880-6. PubMed ID: 25684955
[TBL] [Abstract][Full Text] [Related]
23. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
Jornayvaz FR; Assouline B; Pugin J; Gariani K
BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
[TBL] [Abstract][Full Text] [Related]
24. Tacrolimus in corticosteroid-resistant ulcerative colitis.
Matsuhashi N; Nakajima A; Watanabe K; Komeno Y; Suzuki A; Ohnishi S; Omata M; Kondo K; Usui Y; Iwadare JI; Watanabe T; Nagawa H; Muto T
J Gastroenterol; 2000; 35(8):635-40. PubMed ID: 10955604
[TBL] [Abstract][Full Text] [Related]
25. Humoral response to COVID-19 infection in immunosuppressed patients with inflammatory bowel disease.
Scharrer S; Kutschera M; Weseslindtner L; Primas C; Vogelsang H
Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):443-447. PubMed ID: 33522752
[TBL] [Abstract][Full Text] [Related]
26. Ulcerative colitis as a possible sequela of COVID-19 Infection: The endless story.
Elbadry M; Medhat MA; Zaky S; El Kassas M
Arab J Gastroenterol; 2022 May; 23(2):134-137. PubMed ID: 35473685
[TBL] [Abstract][Full Text] [Related]
27. Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?
Monteleone G; Ardizzone S
J Crohns Colitis; 2020 Sep; 14(9):1334-1336. PubMed ID: 32215548
[TBL] [Abstract][Full Text] [Related]
28. Gastrointestinal Pathology in Samples From Coronavirus Disease 2019 (COVID-19)-Positive Patients.
Westerhoff M; Jones D; Hrycaj SM; Chan MP; Pantanowitz L; Tu H; Choi K; Greenson J; Lamps L
Arch Pathol Lab Med; 2021 Sep; 145(9):1062-1068. PubMed ID: 33961007
[TBL] [Abstract][Full Text] [Related]
29. Rapid Induction Therapy with Oral Tacrolimus in Elderly Patients with Refractory Ulcerative Colitis Can Easily Lead to Elevated Tacrolimus Concentrations in Blood: A Report of 5 Cases.
Kawamura H; Matsumoto S; Nakamura N; Miyatani H; Mashima H
Am J Case Rep; 2017 Apr; 18():405-409. PubMed ID: 28411286
[TBL] [Abstract][Full Text] [Related]
30. Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options.
Bourgonje AR; van Linschoten RCA; West RL; van Dijk MA; van Leer-Buter CC; Kats-Ugurlu G; Pierik MJ; Festen EAM; Weersma RK; Dijkstra G
Therap Adv Gastroenterol; 2021; 14():17562848211012595. PubMed ID: 33995584
[TBL] [Abstract][Full Text] [Related]
31. Ambulatory care management of 69 patients with acute severe ulcerative colitis in comparison to 695 inpatients: insights from a multicentre UK cohort study.
Sebastian S; Patel KV; Segal JP; Subramanian S; Conley TE; Gonzalez HA; Kent AJ; Saifuddin A; Hicks L; Mehta S; Bhala N; Brookes MJ; Lamb CA; Kennedy NA; ; Walker GJ
BMJ Open Gastroenterol; 2022 Jan; 9(1):. PubMed ID: 35101886
[TBL] [Abstract][Full Text] [Related]
32. [Sweet syndrome and erythema nodosum in ulcerative colitis, refractory to steroids: successful treatment with tacrolimus].
Fellermann K; Rudolph B; Witthöft T; Herrlinger KR; Tronnier M; Ludwig D; Stange EF
Med Klin (Munich); 2001 Feb; 96(2):105-8. PubMed ID: 11253280
[TBL] [Abstract][Full Text] [Related]
33. Intravenous tacrolimus is a superior induction therapy for acute severe ulcerative colitis compared to oral tacrolimus.
Shimizu H; Fujii T; Kinoshita K; Kawamoto A; Hibiya S; Takenaka K; Saito E; Nagahori M; Ohtsuka K; Watanabe M; Okamoto R
BMC Gastroenterol; 2021 Dec; 21(1):494. PubMed ID: 34949172
[TBL] [Abstract][Full Text] [Related]
34. Severe
Páramo-Zunzunegui J; Ortega-Fernández I; Calvo-Espino P; Diego-Hernández C; Ariza-Ibarra I; Otazu-Canals L; Danés-Grases JE; Menchero-Sánchez A
Ann R Coll Surg Engl; 2020 Sep; 102(7):e176-e179. PubMed ID: 32803988
[TBL] [Abstract][Full Text] [Related]
35. Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study.
Bezzio C; Armuzzi A; Furfaro F; Ardizzone S; Milla M; Carparelli S; Orlando A; Caprioli FA; Castiglione F; Viganò C; Ribaldone DG; Zingone F; Monterubbianesi R; Imperatore N; Festa S; Daperno M; Scucchi L; Ferronato A; Pastorelli L; Balestrieri P; Ricci C; Cappello M; Felice C; Fiorino G; Saibeni S;
Aliment Pharmacol Ther; 2021 Dec; 54(11-12):1432-1441. PubMed ID: 34694009
[TBL] [Abstract][Full Text] [Related]
36. Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives' on COVID-19 and health care service during the pandemic.
Moum KM; Moum B; Opheim R
Scand J Gastroenterol; 2021 May; 56(5):545-551. PubMed ID: 33771086
[TBL] [Abstract][Full Text] [Related]
37. Rescue therapy with tacrolimus for a patient with severe ulcerative colitis refractory to combination leukocytapheresis and high-dose corticosteroid therapy.
Nakase H; Mikami S; Matsuura M; Ueno S; Uza N; Inoue S; Kitamura H; Kasahara K; Yoshino T; Takeda Y; Chiba T
Intern Med; 2007; 46(11):717-20. PubMed ID: 17541222
[TBL] [Abstract][Full Text] [Related]
38. Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers.
Stallmach A; Sturm A; Blumenstein I; Helwig U; Koletzko S; Lynen P; Schmidt C; Dignass A; Kucharzik T;
Z Gastroenterol; 2020 Oct; 58(10):982-1002. PubMed ID: 33036052
[TBL] [Abstract][Full Text] [Related]
39. COVID-19 Pandemic: Which IBD Patients Need to Be Scoped-Who Gets Scoped Now, Who Can Wait, and how to Resume to Normal.
Ng SC; Mak JWY; Hitz L; Chowers Y; Bernstein CN; Silverberg MS
J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S791-S797. PubMed ID: 33085973
[TBL] [Abstract][Full Text] [Related]
40. Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases.
Brenner EJ; Pigneur B; Focht G; Zhang X; Ungaro RC; Colombel JF; Turner D; Kappelman MD; Ruemmele FM
Clin Gastroenterol Hepatol; 2021 Feb; 19(2):394-396.e5. PubMed ID: 33059040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
